31
Participants
Start Date
June 13, 2022
Primary Completion Date
November 1, 2025
Study Completion Date
November 1, 2025
Dose-escalated adaptive radiotherapy
Adaptive planning of Radiation Therapy with two re-plans of the treatment field through course of therapy with the shrinking treatment fields according to tumor response to escalate dose, as allowed by dose to organs-at-risk.
Chemotherapy
Concurrent standard of care platinum doublet based therapy
RECRUITING
Cross Cancer Institute, Edmonton
AHS Cancer Control Alberta
OTHER